OLENPHOGY Enhances TriPhasic Berberine Formula with GlucoVantage® and Superior Powder Stability

BRANDON, Fla. - Rezul -- OLENPHOGY today announced a comprehensive formulation update for its flagship TriPhasic Berberine system, marking a significant advancement in product physical consistency, batch uniformity, and ingredient quality.

Combining three distinct forms of berberine—standardized Berberine HCl, Liposomal Berberine, and Dihydroberberine—into a single synergistic capsule presented complex manufacturing challenges. Due to the varying particle densities and moisture characteristics of these active isomers, initial production phases required intensive engineering to overcome powder settling and clumping during processing and shelf storage.

Through extensive collaborative testing with its U.S. manufacturing facility, OLENPHOGY's formulation team refined the capsule's physical matrix by incorporating targeted, clean-label functional excipients. These additions optimize powder flowability and dispersion during encapsulation, preventing moisture-induced clumping and ensuring that the physical contents of every capsule remain uniform over time.

More on Rezul News

• Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
• KeysCaribbean Announces Temporarily Reduced Rates At Village at Hawks Cay Villas
• Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
• Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
• Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds

As part of this manufacturing elevation, OLENPHOGY also officially upgraded the formula's Dihydroberberine (DHB) component to GlucoVantage®, a premier patented form known for its high purity, exceptional bioavailability, and superior batch-to-batch stability.

"Merging three distinct berberine delivery systems into one harmonious capsule required months of hands-on refinement on the production floor," said Dr. Marcus Lin, Director of Clinical Research at OLENPHOGY. "By upgrading to patented GlucoVantage® and optimizing our physical matrix, we have ensured that every single capsule delivers consistent active potency, physical stability, and optimal nutrient utilization without compromising our clean-label principles."

The upgraded formula remains 100% vegan, non-GMO, gluten-free, soy-free, and dairy-free. Manufactured in an NSF cGMP-certified and FDA-registered U.S. facility, every batch continues to undergo full third-party lab verification with an accessible Certificate of Analysis (COA).

More on Rezul News

• Hampton Roads Inventory Hits Six-Year High: Capital Valuations Issues Seller Advisory
• "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
• Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
• Hunter's Green's Top Listing Agent Brings Listing and Professional Staging Under One Roof
• Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown

For formulation details, visit: https://olenphogy.com/products/triphasic-berberine

About OLENPHOGY: OLENPHOGY is a U.S.-based premium wellness brand dedicated to smarter, precision-driven supplementation. Built on the principles of science, purity, precision, and efficiency, the brand develops clinically inspired formulas manufactured in cGMP-compliant facilities and validated through multi-stage quality testing to support intentional, informed wellness living.

Contact
Attn: PR Manager Hebe Lee
Email: hello@olenphogy.com
Phone: +1-888-588-6536
Website: https://olenphogy.com